Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zilucoplan Concentration in Breast Milk of Healthy Lactating Women
NCT06961747Phase 1Recruiting
- Sponsor
- UCB
- Start
- Jul 2025
- Primary completion
- Mar 2027
- Modality
- Cyclic Peptides
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of zilucoplan in myasthenia gravis (MG), sponsored by UCB. Primary endpoint: Concentrations of zilucoplan and its major metabolites (RA103488 and RA102758) in breast milk at Day 10. Started Jul 2025; status: recruiting.
02
Drugs
zilucoplan
03
Conditions
myasthenia gravis (MG)
Beyond the preview
Go deeper on NCT06961747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06961747.